Literature DB >> 29947750

Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.

Thomas M Gorter1,2, Masaru Obokata1, Yogesh N V Reddy1, Vojtech Melenovsky1,3, Barry A Borlaug1.   

Abstract

Aims: Pulmonary hypertension (PH) and pulmonary vascular disease (PVD) are common and associated with adverse outcomes in heart failure with preserved ejection fraction (HFpEF). Little is known about the impact of PVD on the pathophysiology of exercise intolerance. Methods and results: Heart failure with preserved ejection fraction patients (n = 161) with elevated pulmonary capillary wedge pressure (≥15 mmHg) at rest were classified into three groups: non-PH-HFpEF (n = 21); PH but no PVD (isolated post-capillary PH, IpcPH; n = 95); and PH with PVD (combined post- and pre-capillary PH, CpcPH; n = 45). At rest, CpcPH-HFpEF patients had more right ventricular (RV) dysfunction and lower pulmonary arterial (PA) compliance compared to all other groups. While right atrial pressure (RAP) and left ventricular transmural pressure (LVTMP) were similar in HFpEF with and without PH or PVD at rest, CpcPH-HFpEF patients demonstrated greater increase in RAP, enhanced ventricular interdependence, and paradoxical reduction in LVTMP during exercise, differing from all other groups (P < 0.05). Lower PA compliance was correlated with greater increase in RAP with exercise. During exercise, CpcPH-HFpEF patients displayed an inability to enhance cardiac output, reduction in forward stroke volume, and blunted augmentation in RV systolic performance, changes that were coupled with marked limitation in aerobic capacity.
Conclusion: Heart failure with preserved ejection fraction patients with PVD demonstrate unique haemodynamic limitations during exercise that constrain aerobic capacity, including impaired recruitment of LV preload due to excessive right heart congestion and blunted RV systolic reserve. Interventions targeted to this distinct pathophysiology require testing in patients with HFpEF and PVD.

Entities:  

Mesh:

Year:  2018        PMID: 29947750      PMCID: PMC6093469          DOI: 10.1093/eurheartj/ehy331

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  41 in total

1.  Right ventricular function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Imad Hussain; Omar F AbouEzzeddine; Omar F Abou Ezzeddine; Hiroyuki Takahama; Susan H Kwon; Paul Forfia; Véronique L Roger; Margaret M Redfield
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

Review 2.  Pulmonary hypertension due to left heart disease.

Authors:  Marco Guazzi; Barry A Borlaug
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

3.  Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.

Authors:  Mads J Andersen; Seok-Jae Hwang; Garvan C Kane; Vojtech Melenovsky; Thomas P Olson; Kenneth Fetterly; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2015-04-09       Impact factor: 8.790

4.  Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study.

Authors:  Masaru Obokata; Garvan C Kane; Yogesh N V Reddy; Thomas P Olson; Vojtech Melenovsky; Barry A Borlaug
Journal:  Circulation       Date:  2016-12-30       Impact factor: 29.690

5.  Percutaneous Pericardial Resection: A Novel Potential Treatment for Heart Failure With Preserved Ejection Fraction.

Authors:  Barry A Borlaug; Rickey E Carter; Vojtech Melenovsky; Christopher V DeSimone; Prakriti Gaba; Ammar Killu; Niyada Naksuk; Lilach Lerman; Samuel J Asirvatham
Journal:  Circ Heart Fail       Date:  2017-04       Impact factor: 8.790

6.  Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.

Authors:  Christian F Opitz; Marius M Hoeper; J Simon R Gibbs; Harald Kaemmerer; Joanna Pepke-Zaba; J Gerry Coghlan; Laura Scelsi; Michele D'Alto; Karen M Olsson; Silvia Ulrich; Werner Scholtz; Uwe Schulz; Ekkehard Grünig; Carmine D Vizza; Gerd Staehler; Leonhard Bruch; Doerte Huscher; David Pittrow; Stephan Rosenkranz
Journal:  J Am Coll Cardiol       Date:  2016-07-26       Impact factor: 24.094

7.  Inhaled Sodium Nitrite Improves Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction.

Authors:  Barry A Borlaug; Vojtech Melenovsky; Katlyn E Koepp
Journal:  Circ Res       Date:  2016-07-25       Impact factor: 17.367

8.  Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction.

Authors:  Barry A Borlaug; Katlyn E Koepp; Vojtech Melenovsky
Journal:  J Am Coll Cardiol       Date:  2015-10-13       Impact factor: 24.094

9.  The hemodynamic basis of exercise intolerance in tricuspid regurgitation.

Authors:  Mads J Andersen; Rick A Nishimura; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2014-09-04       Impact factor: 8.790

10.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

View more
  53 in total

Review 1.  The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging?

Authors:  Masaru Obokata; Yogesh N V Reddy; Barry A Borlaug
Journal:  Heart Fail Clin       Date:  2019-02-02       Impact factor: 3.179

Review 2.  Heart Failure With Preserved Ejection Fraction In Perspective.

Authors:  Marc A Pfeffer; Amil M Shah; Barry A Borlaug
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

3.  The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Katlyn E Koepp; Alexander C Egbe; Brandon Wiley; Barry A Borlaug
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 17.367

4.  The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Brandon Wiley; Katlyn E Koepp; Caitlin C Jorgenson; Alexander Egbe; Vojtech Melenovsky; Rickey E Carter; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

Review 5.  Performance and Interpretation of Invasive Hemodynamic Exercise Testing.

Authors:  C Charles Jain; Barry A Borlaug
Journal:  Chest       Date:  2020-05-28       Impact factor: 9.410

6.  Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction.

Authors:  Jennifer E Ho; Margaret M Redfield; Gregory D Lewis; Walter J Paulus; Carolyn S P Lam
Journal:  Circulation       Date:  2020-11-02       Impact factor: 29.690

7.  The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.

Authors:  Masaru Obokata; Garvan C Kane; Yogesh N V Reddy; Vojtech Melenovsky; Thomas P Olson; Petr Jarolim; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

Review 8.  Diastolic Stress Testing Along the Heart Failure Continuum.

Authors:  T Jake Samuel; Rhys Beaudry; Satyam Sarma; Vlad Zaha; Mark J Haykowsky; Michael D Nelson
Journal:  Curr Heart Fail Rep       Date:  2018-12

9.  Pulmonary Vascular Pressures and Gas Exchange Response to Exercise in Heart Failure With Preserved Ejection Fraction.

Authors:  Caitlin C Fermoyle; Glenn M Stewart; Barry A Borlaug; Bruce D Johnson
Journal:  J Card Fail       Date:  2020-08-01       Impact factor: 5.712

10.  Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.

Authors:  Yogesh N V Reddy; Masaru Obokata; Frederik H Verbrugge; Grace Lin; Barry A Borlaug
Journal:  J Am Coll Cardiol       Date:  2020-09-01       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.